159 related articles for article (PubMed ID: 27389933)
1. Percentage of Peripheral CD19+CD24hiCD38hi Regulatory B Cells in Neonatal Sepsis Patients and Its Functional Implication.
Pan X; Ji Z; Xue J
Med Sci Monit; 2016 Jul; 22():2374-8. PubMed ID: 27389933
[TBL] [Abstract][Full Text] [Related]
2. Marked elevation of circulating CD19
Li S; Ma F; Hao H; Wang D; Gao Y; Zhou J; Li F; Lin HC; Xiao X; Zeng Q
Pediatr Neonatol; 2018 Jun; 59(3):296-304. PubMed ID: 29239829
[TBL] [Abstract][Full Text] [Related]
3. Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple Myeloma.
Bartosińska J; Purkot J; Karczmarczyk A; Chojnacki M; Zaleska J; Własiuk P; Grząśko N; Morawska M; Walter-Croneck A; Usnarska-Zubkiewicz L; Zielińska P; Jamroziak K; Kowal M; Krasowska D; Chodorowska G; Giannopoulos K
Cells; 2021 Feb; 10(2):. PubMed ID: 33669402
[TBL] [Abstract][Full Text] [Related]
4. Circulating CD19+CD24hiCD38hi regulatory B cells as biomarkers of response to methotrexate in early rheumatoid arthritis.
Fortea-Gordo P; Villalba A; Nuño L; Santos-Bórnez MJ; Peiteado D; Monjo I; Puig-Kröger A; Sánchez-Mateos P; Martín-Mola E; Balsa A; Miranda-Carús ME
Rheumatology (Oxford); 2020 Oct; 59(10):3081-3091. PubMed ID: 32417912
[TBL] [Abstract][Full Text] [Related]
5. Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies.
Aybar LT; McGregor JG; Hogan SL; Hu Y; Mendoza CE; Brant EJ; Poulton CJ; Henderson CD; Falk RJ; Bunch DO
Clin Exp Immunol; 2015 May; 180(2):178-88. PubMed ID: 25376552
[TBL] [Abstract][Full Text] [Related]
6. Decreased number of CD19
Li T; Yu Z; Qu Z; Zhang N; Crew R; Jiang Y
Mol Immunol; 2019 Aug; 112():233-239. PubMed ID: 31181422
[TBL] [Abstract][Full Text] [Related]
7. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation.
Flores-Borja F; Bosma A; Ng D; Reddy V; Ehrenstein MR; Isenberg DA; Mauri C
Sci Transl Med; 2013 Feb; 5(173):173ra23. PubMed ID: 23427243
[TBL] [Abstract][Full Text] [Related]
8. CD19
Chen Q; Lai L; Chi X; Lu X; Wu H; Sun J; Wu W; Cai L; Zeng X; Wang C; Chen W; Peng A
Mediators Inflamm; 2020; 2020():3019378. PubMed ID: 32104147
[TBL] [Abstract][Full Text] [Related]
9. Killer (FASL regulatory) B cells are present during latent TB and are induced by BCG stimulation in participants with and without latent tuberculosis.
van Rensburg IC; Loxton AG
Tuberculosis (Edinb); 2018 Jan; 108():114-117. PubMed ID: 29523310
[TBL] [Abstract][Full Text] [Related]
10. CD24
Hasan MM; Thompson-Snipes L; Klintmalm G; Demetris AJ; O'Leary J; Oh S; Joo H
J Immunol; 2019 Oct; 203(8):2110-2120. PubMed ID: 31511354
[TBL] [Abstract][Full Text] [Related]
11. Frequency of CD19
Zhao Q; Jung LK
Pediatr Rheumatol Online J; 2018 Jul; 16(1):44. PubMed ID: 29973221
[TBL] [Abstract][Full Text] [Related]
12. A Lower Proportion of Regulatory B Cells in Patients with Henoch-Schoenlein Purpura Nephritis.
Hu X; Tai J; Qu Z; Zhao S; Zhang L; Li M; Sun X; Jiang Y
PLoS One; 2016; 11(3):e0152368. PubMed ID: 27030970
[TBL] [Abstract][Full Text] [Related]
13. Effect of CD40/CD40L signaling on IL-10-producing regulatory B cells in Chinese children with Henoch-Schönlein purpura nephritis.
Yang B; Tan X; Xiong X; Wu D; Zhang G; Wang M; Dong S; Liu W; Yang H; Li Q
Immunol Res; 2017 Jun; 65(3):592-604. PubMed ID: 27837410
[TBL] [Abstract][Full Text] [Related]
14. Peripheral CD19+CD24
Piloni D; Morosini M; Magni S; Balderacchi A; Inghilleri S; Cova E; Oggionni T; Frangipane V; Pandolfi L; Scudeller L; Meloni F
Transpl Immunol; 2019 Dec; 57():101245. PubMed ID: 31526864
[TBL] [Abstract][Full Text] [Related]
15. The role of CD19+ CD24high CD38high and CD19+ CD24high CD27+ regulatory B cells in patients with type 1 autoimmune pancreatitis.
Sumimoto K; Uchida K; Kusuda T; Mitsuyama T; Sakaguchi Y; Fukui T; Matsushita M; Takaoka M; Nishio A; Okazaki K
Pancreatology; 2014; 14(3):193-200. PubMed ID: 24854615
[TBL] [Abstract][Full Text] [Related]
16. Characterization of B cells in healthy pregnant women from late pregnancy to post-partum: a prospective observational study.
Lima J; Martins C; Leandro MJ; Nunes G; Sousa MJ; Branco JC; Borrego LM
BMC Pregnancy Childbirth; 2016 Jun; 16(1):139. PubMed ID: 27267973
[TBL] [Abstract][Full Text] [Related]
17. The correlation of CD19 + CD24 + CD38 + B cells and other clinicopathological variables with the proportion of circulating Tregs in breast cancer patients.
Gheybi MK; Farrokhi S; Ravanbod MR; Ostovar A; Mehrzad V; Nematollahi P
Breast Cancer; 2017 Nov; 24(6):756-764. PubMed ID: 28429331
[TBL] [Abstract][Full Text] [Related]
18. CD19+CD24hiCD38hiBregs involved in downregulate helper T cells and upregulate regulatory T cells in gastric cancer.
Wang WW; Yuan XL; Chen H; Xie GH; Ma YH; Zheng YX; Zhou YL; Shen LS
Oncotarget; 2015 Oct; 6(32):33486-99. PubMed ID: 26378021
[TBL] [Abstract][Full Text] [Related]
19. Chronic obstructive pulmonary disease is characterized by reduced levels and defective suppressive function of regulatory B cells in peripheral blood.
Lin S; Ma Z; Huang Y; Sun Y; Yi H
Mol Immunol; 2022 Jan; 141():87-93. PubMed ID: 34837778
[TBL] [Abstract][Full Text] [Related]
20. Increased frequency of circulating CD19+CD24hiCD38hi B cells with regulatory capacity in patients with Ankylosing spondylitis (AS) naïve for biological agents.
Bautista-Caro MB; de Miguel E; Peiteado D; Plasencia-Rodríguez C; Villalba A; Monjo-Henry I; Puig-Kröger A; Sánchez-Mateos P; Martín-Mola E; Miranda-Carús ME
PLoS One; 2017; 12(7):e0180726. PubMed ID: 28683133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
